Herpes simplex virus 1 tropism for human sensory ganglion neurons in the severe combined immunodeficiency mouse model of neuropathogenesis

Journal of Virology

Volumn 87, Issue 5, 2013, Pages 2791-2802

  Zerboni, Leigh ^a   Che, Xibing ^a   Reichelt, Mike ^a   Qiao, Yanli ^a   Gu, Haidong ^b   Arvin, Ann ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LUCIFERASE; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; LATENT PERIOD; LUNG FIBROBLAST; MALE; MOUSE; NERVE CELL MEMBRANE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SATELLITE CELL; SCID MOUSE; SENSORY GANGLION; SEVERE COMBINED IMMUNODEFICIENCY; SPINAL GANGLION; TRANSMISSION ELECTRON MICROSCOPY; VARICELLA ZOSTER VIRUS; VIRAL TROPISM; VIRION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS VIRULENCE;

ACYCLOVIR; ANIMALS; GANGLIA, SPINAL; GENE EXPRESSION; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HERPESVIRUS 3, HUMAN; HUMANS; LUCIFERASES; MICE; MICE, SCID; SATELLITE CELLS, PERINEURONAL; SEVERE COMBINED IMMUNODEFICIENCY; TRANSPLANTATION, HETEROLOGOUS; VALINE; VIRAL PROTEINS; VIRAL TROPISM; VIRUS LATENCY; VIRUS REPLICATION;

EID: 84874726326     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01375-12     Document Type: Article

References (46)

1. Roizman B, Knipe DM, Whitley RJ. 2007. Herpes simplex viruses, p 2502-2601. In Knipe DM, Howley PM (ed), Fields virology, 5th ed, vol 2. Wolters Kluwer, Lippincott, Williams, and Wilkins, Philadelphia, PA.
2. Sawtell NM. 1998. The probability of in vivo reactivation of herpes simplex virus type 1 increases with the number of latently infected neurons in the ganglia. J. Virol. 72:6888-6892.
3. Spruance SL, Overall JC, Jr, Kern ER, Krueger GG, Pliam V, Miller W. 1977. The natural history of recurrent herpes simplex labialis: implications for antiviral therapy. N. Engl. J. Med. 297:69-75.
4. Whitley R (ed). 2001. Herpes simplex viruses, 4th ed, vol 2. Lippincott Williams & Wilkins, Philadelphia, PA.
5. Roizman B, Zhou G, Du T. 2011. Checkpoints in productive and latent infections with herpes simplex virus 1: conceptualization of the issues. J. Neurovirol. 17:512-517.
6. Henderson G, Jaber T, Carpenter D, Wechsler SL, Jones C. 2009. Identification of herpes simplex virus type 1 proteins encoded within the first 1.5 kb of the latency-associated transcript. J. Neurovirol. 15:439-448.
7. Maillet S, Naas T, Crepin S, Roque-Afonso AM, Lafay F, Efstathiou S, Labetoulle M. 2006. Herpes simplex virus type 1 latently infected neurons differentially express latency-associated and ICP0 transcripts. J. Virol. 80: 9310-9321.
8. Leib DA, Bogard CL, Kosz-Vnenchak M, Hicks KA, Coen DM, Knipe DM, Schaffer PA. 1989. A deletion mutant of the latency-associated transcript of herpes simplex virus type 1 reactivates from the latent state with reduced frequency. J. Virol. 63:2893-2900.
9. Perng GC, Jones C, Ciacci-Zanella J, Stone M, Henderson G, Yukht A, Slanina SM, Hofman FM, Ghiasi H, Nesburn AB, Wechsler SL. 2000. Virus-induced neuronal apoptosis blocked by the herpes simplex virus latency-associated transcript. Science 287:1500-1503.
10. Sawtell NM. 2005. Detection and quantification of the rare latently infected cell undergoing herpes simplex virus transcriptional activation in the nervous system in vivo. Methods Mol. Biol. 292:57-72.
11. Devi-Rao GB, Bloom DC, Stevens JG, Wagner EK. 1994. Herpes simplex virus type 1DNAreplication and gene expression during explant-induced reactivation of latently infected murine sensory ganglia. J. Virol. 68:1271- 1282.
12. Wagner EK, Bloom DC. 1997. Experimental investigation of herpes simplex virus latency. Clin. Microbiol. Rev. 10:419-443.
13. Arthur JL, Scarpini CG, Connor V, Lachmann RH, Tolkovsky AM, Efstathiou S. 2001. Herpes simplex virus type 1 promoter activity during latency establishment, maintenance, and reactivation in primary dorsal root neurons in vitro. J. Virol. 75:3885-3895.
14. Bertke AS, Swanson SM, Chen J, Imai Y, Kinchington PR, Margolis TP. 2011. A5-positive primary sensory neurons are nonpermissive for productive infection with herpes simplex virus 1 in vitro. J. Virol. 85:6669-6677.
15. Camarena V, Kobayashi M, Kim JY, Roehm P, Perez R, Gardner J, Wilson AC, Mohr I, Chao MV. 2010. Nature and duration of growth factor signaling through receptor tyrosine kinases regulates HSV-1 latency in neurons. Cell Host Microbe 8:320-330.
16. Hill JM, Garza HH, Jr, Helmy MF, Cook SD, Osborne PA, Johnson EM, Jr, Thompson HW, Green LC, O'Callaghan RJ, Gebhardt BM. 1997. Nerve growth factor antibody stimulates reactivation of ocular herpes simplex virus type 1 in latently infected rabbits. J. Neurovirol. 3:206-211.
17. Webre JM, Hill JM, Nolan NM, Clement C, McFerrin HE, Bhattacharjee PS, Hsia V, Neumann DM, Foster , Lukiw WJ, Thompson HW. 2012. Rabbit and mouse models of HSV-1 latency, reactivation, and recurrent eye diseases. J. Biomed. Biotechnol. 2012:612316.
18. Wilcox CL, Johnson EM, Jr. 1987. Nerve growth factor deprivation results in the reactivation of latent herpes simplex virus in vitro. J. Virol. 61:2311-2315.
19. Zerboni L, Ku CC, Jones CD, Zehnder JL, Arvin AM. 2005. Varicellazoster virus infection of human dorsal root ganglia in vivo. Proc. Natl. Acad. Sci. U. S. A. 102:6490-6495.
20. Zerboni L, Reichelt M, Arvin A. 2010. Varicella-zoster virus neurotropism in SCID mouse-human dorsal root ganglia xenografts. Curr. Top. Microbiol. Immunol. 342:255-276.
21. Zerboni L, Reichelt M, Jones CD, Zehnder JL, Ito H, Arvin AM. 2007. Aberrant infection and persistence of varicella-zoster virus in human dorsal root ganglia in vivo in the absence of glycoprotein I. Proc. Natl. Acad. Sci. U. S. A. 104:14086-14091.
22. Reichelt M, Zerboni L, Arvin AM. 2008. Mechanisms of varicella-zoster virus neuropathogenesis in human dorsal root ganglia. J. Virol. 82:3971-3983.
23. Horsburgh BC, Hubinette MM, Tufaro F. 1999. Genetic manipulation of herpes simplex virus using bacterial artificial chromosomes. Methods Enzymol. 306:337-352.
24. He B, Chou J, Liebermann DA, Hoffman B, Roizman B. 1996. The carboxyl terminus of the murine MyD116 gene substitutes for the corresponding domain of the gamma(1)34.5 gene of herpes simplex virus to preclude the premature shutoff of total protein synthesis in infected human cells. J. Virol. 70:84-90.
25. Szpara ML, Tafuri YR, Enquist LW. 2011. Preparation of viral DNA from nucleocapsids. J. Vis. Exp. 2011:e3151. doi:10.3791/3151.
26. Margolis TP, Imai Y, Yang L, Vallas V, Krause PR. 2007. Herpes simplex virus type 2 (HSV-2) establishes latent infection in a different population of ganglionic neurons than HSV-1: role of latency-associated transcripts. J. Virol. 81:1872-1878.
27. Markovitz NS, Roizman B. 2000. Replication-competent herpes simplex viral vectors for cancer therapy. Adv. Virus Res. 55:409-424.
28. Gesser RM, Valyi-Nagy T, Fraser NW. 1994. Restricted herpes simplex virus type 1 gene expression within sensory neurons in the absence of functional B and T lymphocytes. Virology 200:791-795.
29. Hafezi W, Lorentzen EU, Eing BR, Muller M, King NJ, Klupp B, Mettenleiter TC, Kuhn JE. 2012. Entry of herpes simplex virus type 1 (HSV-1) into the distal axons of trigeminal neurons favors the onset of nonproductive, silent infection. PLoS Pathog. 8:e1002679. doi:10.1371 /journal.ppat.1002679.
30. Davido DJ, Leib DA. 1996. Role of cis-acting sequences of the ICPO promoter of herpes simplex virus type 1 in viral pathogenesis, latency and reactivation. J. Gen. Virol. 77(Part 8):1853-1863.
31. De Regge N, Van Opdenbosch N, Nauwynck HJ, Efstathiou S, Favoreel HW. 2010. Interferon alpha induces establishment of alphaherpesvirus latency in sensory neurons in vitro. PLoS One 5:e13076. doi:10.1371 /journal.pone.0013076.
32. Halford WP, Weisend C, Grace J, Soboleski M, Carr DJ, Balliet JW, Imai Y, Margolis TP, Gebhardt BM. 2006. ICP0 antagonizes Stat 1-dependent repression of herpes simplex virus: implications for the regulation of viral latency. Virol. J. 3:44.
33. Sainz B, Jr, Halford WP. 2002. Alpha/beta interferon and gamma interferon synergize to inhibit the replication of herpes simplex virus type 1. J. Virol. 76:11541-11550.
34. Bertke AS, Patel A, Krause PR. 2007. Herpes simplex virus latencyassociated transcript sequence downstream of the promoter influences type-specific reactivation and viral neurotropism. J. Virol. 81:6605-6613.
35. LaVail JH, Johnson WE, Spencer LC. 1993. Immunohistochemical identification of trigeminal ganglion neurons that innervate the mouse cornea: relevance to intercellular spread of herpes simplex virus. J. Comp. Neurol. 327:133-140.
36. Sawtell NM, Thompson RL. 1992. Herpes simplex virus type 1 latencyassociated transcription unit promotes anatomical site-dependent establishment and reactivation from latency. J. Virol. 66:2157-2169.
37. Yang L, Voytek CC, Margolis TP. 2000. Immunohistochemical analysis of primary sensory neurons latently infected with herpes simplex virus type 1. J. Virol. 74:209-217.
38. Mu X, Silos-Santiago I, Carroll SL, Snider WD. 1993. Neurotrophin receptor genes are expressed in distinct patterns in developing dorsal root ganglia. J. Neurosci. 13:4029-4041.
39. Feldman LT, Ellison AR, Voytek CC, Yang L, Krause P, Margolis TP. 2002. Spontaneous molecular reactivation of herpes simplex virus type 1 latency in mice. Proc. Natl. Acad. Sci. U. S. A. 99:978-983.
40. Margolis TP, Dawson CR, LaVail JH. 1992. Herpes simplex viral infection of the mouse trigeminal ganglion. Immunohistochemical analysis of cell populations. Invest. Ophthalmol. Vis. Sci. 33:259-267.
41. Margolis TP, Elfman FL, Leib D, Pakpour N, Apakupakul K, Imai Y, Voytek C. 2007. Spontaneous reactivation of herpes simplex virus type 1 in latently infected murine sensory ganglia. J. Virol. 81:11069-11074.
42. Wang K, Lau TY, Morales M, Mont EK, Straus SE. 2005. Laser-capture microdissection: refining estimates of the quantity and distribution of latent herpes simplex virus 1 and varicella-zoster virus DNA in human trigeminal Ganglia at the single-cell level. J. Virol. 79:14079-14087.
43. Minagawa H, Sakuma S, Mohri S, Mori R, Watanabe T. 1988. Herpes simplex virus type 1 infection in mice with severe combined immunodeficiency (SCID). Arch. Virol. 103:73-82.
44. Minagawa H, Yanagi Y. 2000. Latent herpes simplex virus-1 infection in SCID mice transferred with immune CD4+T cells: a new model for latency. Arch. Virol. 145:2259-2272.
45. Valyi-Nagy T, Deshmane SL, Raengsakulrach B, Nicosia M, Gesser RM, Wysocka M, Dillner A, Fraser NW. 1992. Herpes simplex virus type 1 mutant strain in1814 establishes a unique, slowly progressing infection in SCID mice. J. Virol. 66:7336-7345.
46. Verjans GM, Hintzen RQ, van Dun JM, Poot A, Milikan JC, Laman JD, Langerak AW, Kinchington PR, Osterhaus AD. 2007. Selective retention of herpes simplex virus-specific T cells in latently infected human trigeminal ganglia. Proc. Natl. Acad. Sci. U. S. A. 104:3496-3501.